@article{UBHD-68819299,
  author={Grass, Jana and Rose, Peter and Burhenne, J{\"u}rgen and Blank, Antje and Haefeli, Walter E. and Mikus, Gerd},
  title={Absolute bioavailability of microdosed midazolam after buccal administration is dependent on buccal exposure time},
  year={2021},
  pages={472-479},
  language={eng},
  issn={1552-4604},
  volume={61},
  number={4},
  note={First published: 25 September 2020 ; Gesehen am 13.12.2021},
  journal={Journal of clinical pharmacology},
  doi={10.1002/jcph.1751},
  url={https://doi.org/10.1002/jcph.1751},
  library={UB},
}
@article{UBHD-68920678,
  author={Rose, Peter and van den Engel, Natasja K. and Kovács, Julia R. and Hatz, Rudolf A. and Boon, Louis and Winter, Hauke},
  title={Anti-Gr-1 antibody provides short-term depletion of MDSC in lymphodepleted mice with active-specific melanoma therapy},
  year={2022},
  pages={1-19},
  language={eng},
  issn={2076-393X},
  volume={10},
  note={Gesehen am 20.05.2022},
  journal={Vaccines},
  doi={10.3390/vaccines10040560},
}
@article{UBHD-69043906,
  author={Stoll, Felicitas E. and Seidel-Gl{\"a}tzer, Andrea and Burghaus, Ina and G{\"o}ring, Oliver and Sauter, Max and Rose, Peter and Daniel, Volker and Haag, Mathias and Schwab, Matthias and Riffel, Johannes and André, Florian and Taylor, Lenka A. and Weiß, Johanna and Burhenne, J{\"u}rgen and Cleeves, Volker and Haefeli, Walter E. and Blank, Antje},
  title={Metabolic effect of blocking sodium-taurocholate co-transporting polypeptide in hypercholesterolemic humans with a twelve-week course of bulevirtide},
  subtitle={n exploratory phase I clinical trial},
  year={2022},
  pages={1-16},
  language={eng},
  issn={1422-0067 and 1661-6596},
  volume={23},
  note={Gesehen am 21.02.2023},
  journal={International journal of molecular sciences},
  doi={10.3390/ijms232415924},
}
@article{UBHD-68770216,
  author={Vay, Manuela and Meyer, Marleen J. and Blank, Antje and Skopp, Gisela and Rose, Peter and Tzvetkov, Mladen Vassilev and Mikus, Gerd},
  title={Oral yohimbine as a new probe drug to predict CYP2D6 activity},
  subtitle={results of a fixed-sequence phase I trial},
  year={2020},
  pages={927-939},
  language={eng},
  issn={1179-1926},
  volume={59},
  number={7},
  note={Gesehen am 12.08.2021},
  journal={Clinical pharmacokinetics},
  doi={10.1007/s40262-020-00862-6},
  url={https://doi.org/10.1007/s40262-020-00862-6},
  library={UB},
}